Proto Labs (PRLB): Revisiting Valuation After This Year’s Strong Share Price Run

Simply Wall St

Proto Labs (PRLB) has quietly put together a strong run this year, with the stock up about 37% year to date and roughly 20% over the past year, outpacing many industrial peers.

See our latest analysis for Proto Labs.

That momentum has not come out of nowhere, with a 7.5% 1 month share price return and a 20.2% 1 year total shareholder return suggesting investors are steadily warming to Proto Labs growth and risk profile.

If Proto Labs has you rethinking your watchlist, this is a good moment to broaden your search and discover fast growing stocks with high insider ownership.

With shares now trading close to analyst targets and recent earnings improving, investors face a key question: Is Proto Labs still flying under the radar, or is the market already pricing in its next leg of growth?

Most Popular Narrative: 6.1% Undervalued

With Proto Labs last closing at $53.22 versus a narrative fair value near $56.67, the story leans toward modest upside built on improving fundamentals.

Continued strong cash generation, with a debt free balance sheet and share repurchases, provides flexibility to invest in automation, profitability (through digital workflow/AI optimization), and global expansion, which supports both margin improvement and long term earnings growth.

Read the complete narrative.

Curious how steady mid single digit growth can still justify a premium style multiple, driven by expanding margins and shrinking share count. Want the full playbook behind that valuation call.

Result: Fair Value of $56.67 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, sustained European weakness and heavy reliance on a few large aerospace and defense customers could quickly undermine that steady growth and margin story.

Find out about the key risks to this Proto Labs narrative.

Another Way of Looking at Value

While the narrative fair value suggests modest upside, our earnings multiple view is far more cautious. Proto Labs trades on a steep 84.9x P/E versus a fair ratio of 32.5x, well above both the US Machinery industry at 25.7x and peers at 30.8x. This points to meaningful valuation risk if expectations slip and raises the question of whether sentiment is now running ahead of fundamentals.

See what the numbers say about this price — find out in our valuation breakdown.

NYSE:PRLB PE Ratio as at Dec 2025

Build Your Own Proto Labs Narrative

If you see the story differently or prefer to dig through the numbers yourself, you can build a personalized view in just minutes: Do it your way.

A great starting point for your Proto Labs research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.

Looking for more investment ideas?

Before the market moves on without you, put Simply Wall Street to work and uncover fresh opportunities that match your strategy in minutes.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Proto Labs might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com